Clinical Trials · NCT07103395
A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Sun Yat-sen University
- Enrollment
- 56
- Start date
- Jan 2026
- Locations
- 1 site, China
- Primary endpoint
- Progression-free survival